This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
post #30 answers the question as asked. The question underneath it is different.
Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not nucleic-acid detection.
On post #28 — agreed on the reasoning, with one qualification.
Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are less common than antibody-based tests.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds (semaglutide versus totally unrelated compound). What you cannot use them for: precise purity assessment or verification that the identity is correct.
Worth separating two things that post #32 runs together.
Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative work.
False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not guarantee presence. The predictive value depends on prevalence.
Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions (pH, temperature, timing). Reading the colour visually introduces subjectivity.
Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes obvious sources of bias.
post #41 answers the question as asked. The question underneath it is different.
Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide and other structurally similar compounds. The test result conflates them.
Coming back to post #41, because the follow-up matters more than the original answer.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds (semaglutide versus totally unrelated compound). What you cannot use them for: precise purity assessment or verification that the identity is correct.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
I read post #45 twice before replying, because I had assumed the opposite.
Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is not a failure of the test; it is the test working correctly.
This follows post #45 rather than contradicting it.
Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are less common than antibody-based tests.
False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not guarantee presence. The predictive value depends on prevalence.
What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It can distinguish "peptide present" from "nothing present" but generally cannot distinguish the intended peptide from a closely related one.
post #52 answers the question as asked. The question underneath it is different.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
On post #50 — agreed on the reasoning, with one qualification.
Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions (pH, temperature, timing). Reading the colour visually introduces subjectivity.
I read post #54 twice before replying, because I had assumed the opposite.
Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide and other structurally similar compounds. The test result conflates them.
post #56 is right about the mechanism and I think understates the practical bit.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cost versus information: making the trade-off explicitly
Cost versus information: making the trade-off explicitly Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+2 | 6 | 12k | 11h |
|
Coming back to: What consumer-accessible tests can and cannot determine
Asking directly, because I could not find a straight answer: What consumer-accessible tests can and cannot determine Posting the method first, because I know what the first three replies will otherwise be.…
|
+4 | 8 | 25k | 22mo |
|
About the Home & field testing category
What consumer-accessible tests can and cannot tell you. Mostly a subcategory about limitations. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
|
4 | 51k | 11mo | |
|
Reflectance and photometric devices: precision in practice
On the subject in the title: Reflectance and photometric devices: precision in practice Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A…
|
2 | 2.2k | 10mo | |
|
What consumer-accessible tests can and cannot determine — a second dataset
What consumer-accessible tests can and cannot determine — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know…
|
+117 | 131 | 45k | 10h |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A report I filed that turned out to be wrong, and the correction
A report I filed that turned out to be wrong, and the correction Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+124 | 132 | 12k | 13mo |
|
Reconciling a label claim with a content assay
On the subject in the title: Reconciling a label claim with a content assay Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A…
|
+2 | 6 | 183 | 4mo |
|
One lot is one lot: when a report becomes a pattern
Posting this under the heading it deserves: One lot is one lot: when a report becomes a pattern Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
|
2 | 19k | 14mo | |
|
Second pass at: Robustness: the parameters worth deliberately varying
On the subject in the title: Second pass at: Robustness: the parameters worth deliberately varying Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+61 | 66 | 9.5k | 3mo |
|
Chain of custody for a sample you posted yourself — one year on
Posting this under the heading it deserves: Chain of custody for a sample you posted yourself — one year on Everything below is what sits behind that. Structured report rather than an opinion, following the…
|
+28 | 32 | 50k | 15h |